Brunner Investment trust's Jeremy Thomas gives a run-down of his favourite high yielding stocks from across the globe, including Switzerland, Australia and the US.
Many managers are expecting a correction in the UK market. But with prices at current levels, market rotations could continue without much change in the overall level of the All-Share, argues Premier Asset Management's Chris White.
Threadneedle global emerging market manager Irina Miklavchich explains why she has topped up holdings in Asian tech companies, and is closely watching the trouble brewing in China's real estate sector.
Regulations forcing companies to improve energy efficiency have created a growing customer base for companies selling products that help save energy. Tim Dieppe, partner and fund manager at sustainability specialists WHEB Group explains why he has bought...
The weaker yen is proving a drag on consumer incomes, and the real, structural change that will help Japan recovery is yet to be seen. Internationally-diversified market leaders will be the best way to play the market, explains Aberdeen Asset Management's...
Fresh back from a trip to Asia, Mirabaud Asset Management's Daniel Tubbs takes a look at the political and macroeconomic positions of 'the Switzerland of Asia' - Singapore - and Thailand.
All boats rose with the tide in the recent frontier market rally. But for more discerning investors, Nigerian banks, Saudi Arabian healthcare and the Pakistani stock market all stand out as innovative ways to play the next market leg-up. Duet manager...
This week Japan's prime minister Shinzo Abe returned with a ‘third arrow' plan for structural reform. Wether his plans succeed remains to be seen but other factors mean sustained recovery is on the cards for Japan, says Andrew Rose, manager of the Schroder...
The biotech sector has stumbled in recent months as investors have moved to take profits on the industry's boom. Daniel Koller, manager of the BB Biotech fund, outlines the new breed of drugs set to push the sector higher.